Thomas Bourgeron
Professor
University Paris Diderot
From this contributor
Expliquer la résilience à l’autisme peut faire naître de nouvelles thérapies
Explaining ‘resilience’ in autism may seed new therapies
Some individuals who have autism mutations show no signs of the condition; understanding why may lead to treatments.
Explaining ‘resilience’ in autism may seed new therapies
Questions for Thomas Bourgeron: In search of ‘second hits’
Taking a close look at people who have a mutation in a known autism gene may reveal why these people often have vastly different characteristics.
Questions for Thomas Bourgeron: In search of ‘second hits’
Explore more from The Transmitter
Sylvia Fogel, reshaping U.S. autism research strategy
In a wide-ranging and provocative interview, the chair of the federal Interagency Autism Coordinating Committee shares her views on vaccines, regression, neuroimmune conditions and more.
Sylvia Fogel, reshaping U.S. autism research strategy
In a wide-ranging and provocative interview, the chair of the federal Interagency Autism Coordinating Committee shares her views on vaccines, regression, neuroimmune conditions and more.
Human brain organoids flourish in emptied mouse cortex
The chimeric mice could help untangle the biology of human brain development or conditions such as autism.
Human brain organoids flourish in emptied mouse cortex
The chimeric mice could help untangle the biology of human brain development or conditions such as autism.
What if Hegel were a neuroscientist?
Andrea Gambarotto shares what Hegel and enactivism have in common: an agency-first approach to understanding minds and brains.
What if Hegel were a neuroscientist?
Andrea Gambarotto shares what Hegel and enactivism have in common: an agency-first approach to understanding minds and brains.